Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
11/19/2004 | CA2465004A1 Composition |
11/18/2004 | WO2004098627A1 Inhibition of platelet aggregation through acyclovir and two peptide antagonists |
11/18/2004 | WO2004082573A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4) |
11/18/2004 | WO2004038406A3 Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42) |
11/18/2004 | WO2004035132A3 Compositions and methods for inducing osteogenesis |
11/18/2004 | WO2004002528A9 Compositions and methods for therapeutic treatment |
11/18/2004 | WO2003038043A3 Combinations of dr5 antibody and other therapeutic agents |
11/18/2004 | WO2003037913A3 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
11/18/2004 | US20040231005 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases |
11/18/2004 | US20040230037 Chemokine receptor materials and methods |
11/18/2004 | US20040229919 As diuretic agent, as an agent for preventing heart or heart tissue damages caused by metabolic or ionic abnormalities associated with ischemia, in the treatment of thrombosis, angina pectoris, asthma, hypertension, nephroedema, pulmonary edema, primary and secondary aldosteronism, Bartter's syndrome |
11/18/2004 | US20040229897 Aid in cytokine biosynthesis |
11/18/2004 | US20040229884 Sodium channel blockers |
11/18/2004 | US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists |
11/18/2004 | US20040229875 Administering compounds such as 4-(2-Amino-5-phenyl-pyrimidin-4-yl)-1H-pyrrole-2-carboxylic acid dimethylamide for therapy of transplant rejection, melanoma, or a cancer selected from colon, breast, lung, kidney, ovary, pancreas, CNS, or cancer of the gastric tract |
11/18/2004 | US20040229872 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity |
11/18/2004 | US20040229870 Certain alkylene diamine-substituted heterocycles |
11/18/2004 | US20040229806 Hirulog-like peptide and gene therapy |
11/18/2004 | US20040229333 Electroprocessed fibrin-based matrices and tissues |
11/17/2004 | EP1477175A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
11/17/2004 | EP1476752A1 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome |
11/17/2004 | EP1476545A2 Aggrecanase molecules |
11/17/2004 | EP1476541A2 Novel cytokine zcytor17 ligand |
11/17/2004 | EP1476471A1 Nutraceuticals for the treatment, protection and restoration of connective tissues |
11/17/2004 | EP1476461A2 Immune-modulating peptide made of s. aureus enterotoxin b |
11/17/2004 | EP1476460A2 A nucleic acid encoding a g-protein-coupled receptor; and uses thereof |
11/17/2004 | EP1476454A1 Binding epitopes for helicobacter pylori and use thereof |
11/17/2004 | EP1476435A1 Novel pyridin- and pyrimidin-derivatives |
11/17/2004 | EP1476432A1 Therapeutic substituted indazole derivatives |
11/17/2004 | EP1476429A1 Novel pyridine- and quinoline-derivatives |
11/17/2004 | EP1476421A2 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
11/17/2004 | EP1476186A1 Use of an inhibitor or antagonist against tissue factor |
11/17/2004 | EP1476159A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof |
11/17/2004 | EP1476158A1 Nicotinamide derivatives useful as pde4 inhibitors |
11/17/2004 | EP1476157A1 Nicotinamide derivatives useful as pde4 inhibitors |
11/17/2004 | EP1476154A2 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases |
11/17/2004 | EP1318804B1 Iron compositions |
11/17/2004 | EP1289980B1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides |
11/17/2004 | EP1242413B1 Substituted 1,3,4-oxadiazoles and a method of reducing tnf-alpha levels |
11/17/2004 | EP1214323B1 Indoloazepines as vasopressin receptor antagonists |
11/17/2004 | EP1082321B1 Heterocyclic derivatives which inhibit factor xa |
11/17/2004 | CN1547608A Modified factor IX |
11/17/2004 | CN1547583A 多环鸟嘌呤磷酸二酯酶v抑制剂 Polycyclic guanine phosphodiesterase inhibitor v |
11/17/2004 | CN1547482A Use of POLY-GLU,TYR and T cells treated therewith for neuroprotective therapy |
11/17/2004 | CN1547466A Extended release oral dosage form |
11/17/2004 | CN1546491A Pteridine derivatives with nitric oxide synthase inhibitor function |
11/17/2004 | CN1546455A Resveratrol oxo acid derivatives, their preparation and pharmaceutical compositions |
11/17/2004 | CN1546171A Protease inhibitor of Ornithotoctonus huwena |
11/17/2004 | CN1546129A Preparing technics of composition of Guizhi and Fuling and its use |
11/17/2004 | CN1546089A Prescription of Huanyuan Injection and its preparation process and usage |
11/17/2004 | CN1546063A Encephalic proteolytic products of compound Piracetam and its preparation |
11/17/2004 | CN1546032A Freeze dried ginkoleaf extract and diphyridamole powder injecta and its preparation |
11/17/2004 | CN1546026A Dripping pills of perhexiline maleate and its preparation |
11/17/2004 | CN1176105C New anti-embolism medicine using small peptide arginine-glycine-aspartic acid (RGD) as leading compound |
11/17/2004 | CN1176104C Process for preparation of acetyl-guanylphenylalanyl-cyclohexylglycyl-pyridinioalaninamides |
11/17/2004 | CN1175899C Medicine composition and preparation and use thereof |
11/17/2004 | CN1175874C Medicine made of chuan-xiong rhizome for treating thromboangitis obliterans and its prescription |
11/17/2004 | CN1175842C Recipe and preparation process of hemopoietic capsule |
11/17/2004 | CN1175826C Ass hide glue ferrous oral liquor and its production method |
11/16/2004 | US6818646 1,2,3,4-tetrahydro-2-(5-(2-pyridinyl)-pyrimidin-2-yl)-3-(2,3 -dihydrobenzofuranyl)-9h-pyrrolo-(3,4-b)quinolin-9-one; male erectile dysfunction; sexual disorders |
11/16/2004 | US6818632 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia |
11/16/2004 | US6818619 Chimeric natriuretic peptides |
11/16/2004 | US6818613 A parenteral sustained-release formulation of e.g., erythropoietin, that is easily manufactured, safe, stable and efficient comprising the protein, a buffer, tonicity agent and sodium carboxymethylcellulose |
11/16/2004 | US6818233 Dietary supplements containing natural ingredients |
11/16/2004 | US6818196 Heating a mixture of zirconium oxychloride and soda ash at a sufficient temperature and for a sufficient time to form sodium zirconium carbonate |
11/11/2004 | WO2004097320A2 Thermal energy storage |
11/11/2004 | WO2004096268A2 Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke |
11/11/2004 | WO2004096267A1 Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke |
11/11/2004 | WO2004096249A1 A composition containing radix codonopsis pilosulae and radix astragali and hedysari, method of producing it and use thereof |
11/11/2004 | WO2004096228A1 Method of improved diuresis in individuals with impaired renal function |
11/11/2004 | WO2004096204A1 Lactate containing pharmaceutical composition and uses thereof |
11/11/2004 | WO2004073699A8 Pharmaceuticals comprising shikonins as active constituent |
11/11/2004 | WO2004038407A3 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12) |
11/11/2004 | WO2003087411A8 Method to inhibit cell growth using oligonucleotides |
11/11/2004 | WO2003059264A9 Methods for the induction of professional and cytokine-producing regulatory cells |
11/11/2004 | WO2003046574A3 Complement c3 precursor biopolymer markers indicative of insulin resistance |
11/11/2004 | US20040225137 Methods for producing amino substituted chromanes and intermediates thereof |
11/11/2004 | US20040225124 Process for the preparation of 3-spiro'cyclohexam-1,3'-'3h!indolin-2'-one! derivatives |
11/11/2004 | US20040225123 Substituted phenyl naphthalenes as estrogenic agents |
11/11/2004 | US20040225118 31 human secreted proteins |
11/11/2004 | US20040225109 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides |
11/11/2004 | US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
11/11/2004 | US20040225006 Useful in treatment and prophylaxis of conditions mediated by s-CD23 or tumor necrosis factor; autoimmune disease, inflammation, allergy |
11/11/2004 | US20040224985 for controlling weight; pyrrolidine or piperidine compounds |
11/11/2004 | US20040224965 Treatment of cardiovascular disorders, thrombosis, surgery and nhe inhibitors |
11/11/2004 | US20040224945 Novel substituted pyrazole derivatives |
11/11/2004 | US20040224911 Transporters and ion channels |
11/11/2004 | US20040224885 Methods of treating hypertension and compositions for use therein |
11/11/2004 | US20040224864 sterilization of embolic compositions comprising hydroxyl-containing rheological modifier(s) using irradiation techniques provides sterilized compositions exhibiting minimal changes in its thioxotropic behavior; prolonged shelf life with limited changes in viscosity |
11/11/2004 | US20040224360 Methods for diagnosing renal disorders |
11/11/2004 | US20040224356 Novel human enzymes of the metalloprotease family |
11/11/2004 | US20040224314 G-protein coupled receptors |
11/11/2004 | CA2524573A1 Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke |
11/11/2004 | CA2522971A1 Method of improved diuresis in individuals with impaired renal function |
11/10/2004 | EP1475104A1 Stabilized proteinic preparation |
11/10/2004 | EP1475098A1 High-concentration preparation of soluble thrombomodulin |
11/10/2004 | EP1474445A1 Glycoisoforms of adiponectin and uses thereof |
11/10/2004 | EP1474438A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
11/10/2004 | EP1474427A1 Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds |
11/10/2004 | EP1474425A1 Deazapurines and uses thereof |